Spinal cord injury

Sintalica Bioscience Announces Key Approval Milestones from the Italian Health Authority

Retrieved on: 
Wednesday, November 23, 2022
Science, Neurology, Research, Alternative Medicine, Health, University, Education, Clinical Trials, Inflammation, Neurodegeneration, Biotechnology, Chemistry, Partnership, Laboratory, Entrepreneurship, University of Messina, Pharmacology, Research, Safety, Spinal cord injury, University, Tryptamine, Patient, Pharmaceutical industry, Fine chemical, Fibromyalgia, Psilocybin

Sintalicas research and drug development program is focused on neurodegenerative disorders, including SCI-Induced Chronic Neuropathic Pain (Spinal Cord Injury), Fibromyalgia, and Inflammation.

Key Points: 
  • Sintalicas research and drug development program is focused on neurodegenerative disorders, including SCI-Induced Chronic Neuropathic Pain (Spinal Cord Injury), Fibromyalgia, and Inflammation.
  • Sintalica has filed three provisional patents for proprietary psychedelic molecules with claims of improved stability, efficacy and bioavailability.
  • Sintalica has an exclusive research partnership with leading Italian research institutes, including the University of Messina and the University of Niccol Cusano of Rome.
  • Sintalica Bioscience Corp. is a Canadian drug discovery company operating through its Italian subsidiary focused on using psychedelics to create breakthrough treatments for neuroinflammatory disorders.

ONWARD Awarded European Innovation Council Grant to Further Develop Brain-Computer Interface Technology; Company also Wins First Place in 2022 Brain-Computer Interface Awards

Retrieved on: 
Monday, November 21, 2022
Medical Devices, Health, Other Health, Research, Science, Biotechnology, University of California, San Francisco, EUR, CHUV, Euronext, Partnership, Materials Research Science and Engineering Centers, In the First Place, International, SCI, Interface (computing), Stanford University, Swiss Federal Institute of Aquatic Science and Technology, Loss of Sensation, Science, EIC, Quality of life, Spinal cord injury, Hyperreflexia, U.S. FDA, Pathfinder, EPFL, Swiss Federal Institute of Technology, Research, Spinal cord, Paralysis, Nature, Incontinence, Paraplegia, ARC, Record, European Innovation Council, Tetraplegia, Lausanne University Hospital, University, BCI, Movement, Infection, Hope, Health, NEMO, Brain–computer interface, Medical device, Pharmaceutical industry

Separately, ONWARD announced that it was the First Place Winner of the 2022 Brain-Computer Interface (BCI) Award .

Key Points: 
  • Separately, ONWARD announced that it was the First Place Winner of the 2022 Brain-Computer Interface (BCI) Award .
  • The award was granted to ONWARD and several research partners for their submission, Walking naturally after spinal cord injury using a brain-spine interface.
  • ONWARD is a medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injuries.
  • You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release.

Global Bathroom and Toilet Assist Devices Market Analysis Report 2022-2030: Focus on Commodes, Bath Lifts, Bath Aids, Shower Chairs & Stools, Handgrips & Grab Bars, Toilet Seat Raisers - ResearchAndMarkets.com

Retrieved on: 
Thursday, November 17, 2022
Medical Devices, Health, Prevalence, Ageing, Commode, Spinal cord injury, Medicare (United States), Medicare, Medicare Part D, USD, Disability, Accident, COVID-19, Bureau of Labor Statistics, Growth, Health, Conditional sentence, State, Risk, Medicine, Patient, Health insurance

The "Bathroom and Toilet Assist Devices Market Size, Share & Trends Analysis Report by Product (Commodes, Bath Lifts, Bath Aids, Shower Chairs & Stools, Handgrips & Grab Bars, Toilet Seat Raisers), by Region, and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Bathroom and Toilet Assist Devices Market Size, Share & Trends Analysis Report by Product (Commodes, Bath Lifts, Bath Aids, Shower Chairs & Stools, Handgrips & Grab Bars, Toilet Seat Raisers), by Region, and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.
  • The global bathroom and toilet assist devices market size is anticipated to reach USD 8.23 billion by 2030, expanding at a CAGR of 6.4% from 2022 to 2030.
  • Aging demographics have created a demand for old-age homes and long-term care centers, both of which drive demand for bathroom and toilet to assist devices.
  • Old age people are advised to stay at home during the lockdown, which has increased the demand for bathroom and toilet assist devices.

200 Attend Fasano Longevity Conference Focused on Longevity, Medical Research and Politics

Retrieved on: 
Tuesday, November 15, 2022
Legal, Insurance, Human Resources, Finance, Consulting, Banking, Accounting, Professional Services, Small Business, Transfer, Cook, Word Association, DC, Partner, Longevity, Use, Conference, Life expectancy, Life, Research, Augustus A. Bird, Artificial intelligence, Growth, University, The Cook Political Report, Spinal cord injury, Health, Paralysis, Pharmaceutical industry

200 longevity professionals attended the November 7th Fasano Longevity Conference in Washington, DC.

Key Points: 
  • 200 longevity professionals attended the November 7th Fasano Longevity Conference in Washington, DC.
  • The Conference, which was in hybrid format, with about 170 attending in person and 30 attending virtually, focused on a wide range of topics bearing on longevity markets, medical research and the mid-term elections.
  • It covered a very interesting mix of topics bearing on longevity markets and some very interesting research.
  • Next years Fasano Longevity Conference will be held on Monday, November 6th in Washington, DC.

Wellness Tourism Global Market Report 2022: Increased Spending on Sports Tourism Bodes Well for Sector - ResearchAndMarkets.com

Retrieved on: 
Monday, November 14, 2022
Other Health, Health, Vacation, Destinations, Travel, Tourism, Spinal cord injury, American Express, Food, Environment, Fracture, Injury, Person, Physician, Drink, Growth, Travel, Rehabilitation, Health, Patient

The "Wellness Tourism Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Wellness Tourism Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.
  • The regions covered in the wellness tourism market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
  • The increasing tourist spending on cultural and sports tourism is expected to propel the growth of the wellness tourism market going forward.
  • The countries covered in the wellness tourism market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Encompass Health announces plans to build a 50-bed inpatient rehabilitation hospital in Daytona Beach, Florida

Retrieved on: 
Monday, November 21, 2022
Injury, Quality of life, Environment, Encompass Health, Newsroom, Stroke, EHC, Physician, Pharmacy, Nursing, Spinal cord injury, Disease, NYSE, Patient, Hospital, Brain, Medicare, Encompass, Amputation, Health insurance, Health care, Atlantic Ocean

BIRMINGHAM, Ala., Nov. 21, 2022 /PRNewswire/ --Encompass Health Corp. (NYSE: EHC) today announced it plans to build a freestanding, 50-bed inpatient rehabilitation hospital in Daytona Beach, Florida.

Key Points: 
  • BIRMINGHAM, Ala., Nov. 21, 2022 /PRNewswire/ --Encompass Health Corp. (NYSE: EHC) today announced it plans to build a freestanding, 50-bed inpatient rehabilitation hospital in Daytona Beach, Florida.
  • In addition to 24hour nursing care, this hospital will offer physical, occupational and speech therapies to restore functional ability and quality of life.
  • Encompass Health currently has 19 inpatient rehabilitation hospitals in Florida and has announced plans to open an additional seven hospitals in the state over the next several years.
  • Encompass Health (NYSE: EHC) is the largest owner and operator of rehabilitation hospitals in the United States.

National Spine Health Foundation Issues Holiday Safety Guide

Retrieved on: 
Tuesday, November 15, 2022
Online, Spinal cord injury, Human, Neck, Travel, View, Time, Holiday, Spine, Health education, Multimedia, CEO, Risk, Walking, Trapping, Fast food, Online shopping, Tourism

RESTON, Va., Nov. 15, 2022 /PRNewswire/ -- As Americans head into the holiday season, the hustle and bustle of decorating, traveling, and general merriment may lead to an increase in spinal injuries. To help, the National Spine Health Foundation (NSHF) today released a new Holiday Safety Guide to help individuals avoid undue strain on their back or neck.

Key Points: 
  • To help, the National Spine Health Foundation (NSHF) today released a new Holiday Safety Guide to help individuals avoid undue strain on their back or neck.
  • "Some of our most cherished holiday traditions, such as hanging lights and traveling to visit loved ones, can unintentionally cause back or neck injuries," said Dr. Rita Roy, CEO of the National Spine Health Foundation.
  • "This guide will help the whole family safely navigate celebrations and reduce the risk of unintended pain or injury through the new year."
  • To learn more, access the National Spine Health Foundation's Holiday Safety Guide here: https://spinehealth.org/5-holiday-safety-tips/
    The National Spine Health Foundation (NSHF), a 501-C(3) nonprofit organization, is the only patient-centered non-profit organization dedicated to spine health education and advocacy.

Germany’s second largest health insurer withdraws appeal with Federal Social Court, accepts prior ruling of exoskeletons as direct disability compensation

Retrieved on: 
Friday, November 11, 2022
CEO, Risk, Annual report, Hearing, Adoption, Uncertainty, GLOBE, Technology, Quality of life, Phrase, Stroke, SCI, SEC, Spinal cord injury, Spinal cord, Time, Form 10-K, Medicine, Health insurance, Computer data storage, ReWalk

MARLBOROUGH, Mass. and BERLIN, Nov. 11, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), today welcomed the decision by BARMER to accept the prior ruling from the state court that exoskeletons are considered as direct disability compensation and withdraw the pending case at the federal level shortly before the hearing. This outcome means that an eligible insured person with spinal cord injury (SCI) has a legal basis for the supply of an exoskeleton as an orthopedic aid for direct disability compensation in Germany, ReWalk’s largest market for exoskeletons.

Key Points: 
  • This outcome means that an eligible insured person with spinal cord injury (SCI) has a legal basis for the supply of an exoskeleton as an orthopedic aid for direct disability compensation in Germany, ReWalks largest market for exoskeletons.
  • The definition of direct disability compensation applies to medical aids which replace failed and impaired bodily functions to the extent that the person using them is on par with people without disabilities.
  • The successful conclusion of this legal dispute identifying the exoskeleton as direct disability compensation changes the landscape for the eligible paralyzed community, stated Larry Jasinski, CEO of ReWalk.
  • The German healthcare system has led the way in its adoption of exoskeletons for spinal cord injured individuals.

Walking Tricycle For Cerebral Palsy Mobility Assistance Launched By Alinker

Retrieved on: 
Wednesday, November 9, 2022
Muscular dystrophy, Spinal cord injury, Cerebral palsy, Movement, Freedom, Insurance, Arthritis, Residential care, Mobility scooter

Alinker has launched its new non-electric, no-pedal walking bike for people with mobility challenges, designed to grant freedom and long-distance movement to those who otherwise would not be able to access it.

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - November 8, 2022) - Alinker launched its walking tricycle, which allows individuals with cerebral palsy to move under their own power without the need for a walker and without the limitations of an electric scooter.
  • The Alinker is available to everyone, and the company has taken recent steps to make the device more affordable as well.
  • The Alinker is specifically tailored to those who have conditions such as cerebral palsy, spinal cord injuries, muscular dystrophy, and arthritis.
  • They know the importance of human connection and the freedom provided by autonomy, which is what the Alinker has been designed to provide.

ONWARD’s Research Partner .NeuroRestore Publishes Groundbreaking Paper Identifying Neurons that Restore Walking after Paralysis

Retrieved on: 
Thursday, November 10, 2022
Health, Medical Devices, Neurology, Health Technology, Research, Science, Biotechnology, Quality of life, ARC, Forward-looking statement, Health, Partnership, Research, CHUV, Technology, Swiss Federal Institute of Technology, Spinal cord, Neuron, Science, Leg, Spinal cord injury, Lausanne University Hospital, Muscle, SCI, Movement, Company, Program, Walking, Materials Research Science and Engineering Centers, Euronext, Hyperreflexia, EPFL, CEO, U.S. FDA, Swiss Federal Institute of Aquatic Science and Technology, Paralysis, Medical device, Trapping, Nature

The findings published yesterday continue to build our strong knowledge base in spinal cord stimulation to help people with paralysis.

Key Points: 
  • The findings published yesterday continue to build our strong knowledge base in spinal cord stimulation to help people with paralysis.
  • ONWARD is a medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injuries.
  • ONWARDs work builds on more than a decade of basic science and preclinical research conducted at the worlds leading neuroscience laboratories.
  • You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release.